Werewolf Therapeutics Insider Selling Surge: 40,000‑Share Dump Raises Questions About Future Catalyst Plans
Werewolf Therapeutics insider sales spike: 41,000+ shares off‑market, price dips, potential strategic shift—watch upcoming IND‑KINE data for upside.
3 minutes to read